Patents by Inventor Siobhan GLAVEY

Siobhan GLAVEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sialyltransferase ST3GAL6 as a marker for multiple myeloma
    Patent number: 11242566
    Abstract: The present invention relates to the sialyltransferase ST3GAL6 for use as a biomarker for multiple myeloma, and especially as a marker for myelomas with inferior survival rates. The inventors have shown that glycosylation gene expression is dysregulated in Multiple Myeloma and that overexpression of the sialyltransferase ST3GAL6 is associated with inferior survival rates in patients.
    Type: Grant
    Filed: May 17, 2017
    Date of Patent: February 8, 2022
    Assignee: National University of Ireland, Galway
    Inventors: Siobhan Glavey, Lokesh Joshi, Michael O'Dwyer
  • SIALYLTRANSFERASE ST3GAL6 AS A MARKER FOR MULTIPLE MYELOMA
    Publication number: 20170327899
    Abstract: The present invention relates to the sialyltransferase ST3GAL6 for use as a biomarker for multiple myeloma, and especially as a marker for myelomas with inferior survival rates. The inventors have shown that glycosylation gene expression is dysregulated in Multiple Myeloma and that overexpression of the sialyltransferase ST3GAL6 is associated with inferior survival rates in patients.
    Type: Application
    Filed: May 17, 2017
    Publication date: November 16, 2017
    Inventors: Siobhan GLAVEY, Lokesh JOSHI, Michael O'DWYER
  • SIALYLTRANSFERASE ST3GAL6 AS A MARKER FOR MULTIPLE MYELOMA
    Publication number: 20150354007
    Abstract: The present invention relates to the sialyltransferase ST3GAL6 for use as a biomarker for multiple myeloma, and especially as a marker for myelomas with inferior survival rates. The inventors have shown that glycosylation gene expression is dysregulated in Multiple Myeloma and that overexpression of the sialyltransferase ST3GAL6 is associated with inferior survival rates in patients.
    Type: Application
    Filed: October 15, 2013
    Publication date: December 10, 2015
    Inventors: Siobhan GLAVEY, Lokesh JOSHI, Michael O'DWYER